Quality by design applications in biosimilar pharmaceutical products

Accreditation and Quality Assurance

Volumn 13, Issue 12, 2008, Pages 681-690

  Kenett, Ron S ^a,b   Kenett, Dan A ^c  

^a KPA LTD   (Israel)

^b UNIVERSITY OF TURIN   (Italy)

^c TEVA PHARMACEUTICALS   (Israel)

Author keywords

Analytical methods; Biosimilars; Design of experiments; Multivariate methods; Quality by design; Simulation experiments; Specification limits

Indexed keywords

EID: 57349185727     PISSN: 09491775     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00769-008-0459-6     Document Type: Review

References (25)

1. R Bates R Kenett D Steinberg H Wynn 2006 Qual Technol Quant Manage 3 2 161 177
2. Borman P, Nethercote P, Chatfield M, Thompson D, Truman K (2007) Pharm Technol. Available online at: http://pharmtech.findpharma.com/pharmtech/Peer- Reviewed+Research/The-Application-of-Quality-by-Design-to-Analytical/ ArticleStandard/Article/detail/463580
3. Cook S, Patton KA, Bazemore LR (2007) BioPharm Int 20(12):28-37. Available online at: http://biopharminternational.findpharma.com/biopharm/ Outsourcing/Quality-by-Design-in-the-CMO-Environment/ArticleStandard/Article/ detail/478714
4. Food and Drug Administration (2006) Guidance for industry quality systems approach to pharmaceutical cGMP regulations. Available online at: http://www.fda.gov/CDER/guidance/7260fnl.htm
5. C Fuchs R Kenett 1988 Statistician 37 401 411
6. C Fuchs R Kenett 1998 J Qual Technol 19 122 131
7. Fuchs C, Kenett R (1998) Multivariate quality control: theory and applications. Marcel Dekker Inc., New York
8. D Huang T Allen 2005 J R Stat Soc C 54 2 443 463
9. ICH (2006) The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Quality Guideline Q8 Pharmaceutical Development. Available online at: http://www.fda.gov/CbER/gdlns/ichq8pharm.htm
10. Kenett R, Stark Y (2008) Drug development strategy: the interface between QbD and statistical methods. In: Proceedings of the Global Pharmaceutical Conference on Practical Application of QbD in Accelerated Development, Frankfurt, Germany, April 2008. University of Wisconsin, School of Pharmacy, Madison
11. Kenett R, Steinberg D (2006) Quality progress, August, pp 61-65
12. Kenett R, Zacks S (1998) Modern industrial statistics: design and control of quality and reliability. Duxbury Press, San Francisco. Spanish edn 2000, 2nd paperback edn 2002, Chinese edn 2004
13. M Kennedy A O'Hagan 2000 Biometrika 87 1 13
14. R Myers D Montgomery G Vining C Borror S Kowalski 2004 J Qual Technol 36 1 53 77
15. Nasr M (2007) Quality by Design (QbD) - a modern system approach to pharmaceutical development and manufacturing: FDA perspective. FDA Quality Initiatives Workshop, Maryland
16. Nethercote P (2008) Implications of QbD approach on analytical method development, validation, transfer and change control. In: Proceedings of the Global Pharmaceutical Conference on Practical Application of QbD in Accelerated Development, Frankfurt, Germany, April 2008. University of Wisconsin, School of Pharmacy, Madison
17. Niazi K (2006) Handbook of biogeneric therapeutic proteins regulatory, manufacturing, testing, and patent issues. CRC Press, Boca Raton, FL
18. T Orchard 2006 BioPharm 19 34 46
19. C Reese A Wilson M Hamada H Martz K Ryan 2004 Technometrics 46 2 153 164
20. R Romero D Gasquez M Sanshez L Rodriguez M Bagur 2002 LC GC North Am 20 72 80
21. Ruggeri F, Kenett R, Faltin F (eds) (2007) Wiley encyclopedia of statistics in quality and reliability. Wiley, London
22. J Sacks W Welch T Mitchell H Wynn 1989 Stat Sci 4 409 435
23. Santner TJ, Williams BJ, Notz WI (2003) The design and analysis of computer experiments. Springer, New York
24. Schweitzer M (2008) Quality by design for analytical methods-an industry perspective (PhRMA). In: Proceedings of the Global Pharmaceutical Conference on Practical Application of QbD in Accelerated Development, Frankfurt, Germany, April 2008. University of Wisconsin, School of Pharmacy, Madison
25. L Yu 2008 Pharm Res 25 4 781 791